曲霉特异性IgG抗体检测在非中性粒细胞减少侵袭性肺曲霉病诊断中的临床价值
多中心前瞻性对照研究纳入372例临床疑似非中性粒细胞减少侵袭性肺曲霉病患者,最终368例分为侵袭性肺曲霉病组99例和非侵袭性肺曲霉病组269例。血浆曲霉特异性IgG抗体诊断侵袭性肺曲霉病的敏感性高于血清半乳甘露聚糖,但特异性较低;与支气管肺泡灌洗液半乳甘露聚糖相比敏感性相似但特异性较低。曲霉特异性IgG抗体联合支气管肺泡灌洗液半乳甘露聚糖可提高敏感性但降低特异性。
要点
- 曲霉特异性IgG抗体诊断侵袭性肺曲霉病的敏感性高于血清半乳甘露聚糖,但特异性较低。
- 曲霉特异性IgG抗体与支气管肺泡灌洗液半乳甘露聚糖敏感性相似,但特异性较低。
- 曲霉特异性IgG抗体联合支气管肺泡灌洗液半乳甘露聚糖可提高敏感性但降低特异性。
核心结论
- 在非中性粒细胞减少侵袭性肺曲霉病患者中,曲霉特异性IgG抗体的诊断价值优于血清半乳甘露聚糖,略逊于支气管肺泡灌洗液半乳甘露聚糖。
- 考虑到血液样本采集方便,曲霉特异性IgG抗体是非中性粒细胞减少侵袭性肺曲霉病患者良好的筛查和诊断方法,尤其适用于无法耐受侵入性操作的患者。
研究设计与样本
- 多中心、前瞻性、对照研究,纳入2015年2月至2022年8月临床疑似非中性粒细胞减少侵袭性肺曲霉病患者372例。
- 排除4例曲霉定植后,最终368例分为侵袭性肺曲霉病组99例和非侵袭性肺曲霉病组269例(社区获得性肺炎206例、结核22例、非结核分枝杆菌5例、肺脓肿6例、非感染性疾病30例)。
- 采用酶联免疫吸附试验检测血浆样本中的曲霉特异性IgG抗体。
主要发现
- 以≥80 AU/mL为 cut-off 值时,曲霉特异性IgG抗体的敏感性为59.6%,高于血清半乳甘露聚糖(cut-off 值≥1.0)的19.2%(p < 0.0001);特异性为77.0%,低于血清半乳甘露聚糖的96.3%(p < 0.0001)。
- 以≥80 AU/mL为 cut-off 值时,曲霉特异性IgG抗体的敏感性为59.6%,与支气管肺泡灌洗液半乳甘露聚糖(cut-off 值≥1.0)的55.6%相似(p = 0.611);特异性为77.0%,低于支气管肺泡灌洗液半乳甘露聚糖的91.2%(p = 0.001)。
- 曲霉特异性IgG抗体或支气管肺泡灌洗液半乳甘露聚糖任一阳性的联合诊断,敏感性为81.0%,高于单独支气管肺泡灌洗液半乳甘露聚糖的55.6%(p = 0.002);特异性为75.2%,低于单独支气管肺泡灌洗液半乳甘露聚糖的91.2%(p = 0.001)。
- 受试者工作特征曲线显示,曲霉特异性IgG抗体 cut-off 值为56.6 AU/mL时诊断价值最佳,敏感性和特异性分别为77.8%和63.9%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Aspergillus-specific IgG antibody (Asp IgG) has been successfully applied in the diagnosis of chronic pulmonary aspergillosis. We explored its value in nonneutropenic invasive pulmonary aspergillosis (IPA) by a multicenter, prospective, and controlled study. METHODS: We enrolled 372 clinically suspected nonneutropenic patients with IPA from February 2015 to August 2022. After excluding 4 cases with Aspergillus colonization, the remaining 368 cases were finally confirmed as patients with IPA (n = 99), or non-IPA patients (n = 269) consisting of community-acquired pneumonia (n = 206), tuberculosis (n = 22), nontuberculous mycobacteria (n = 5), lung abscess (n = 6), or noninfectious diseases (n = 30). Asp IgG in plasma samples was tested by enzyme-linked immunosorbent assay. RESULTS: At cut-off value of ≥80 AU/mL, Asp IgG had much higher sensitivity (59.6% vs. 19.2%, p < 0.0001), but lower specificity (77.0% vs. 96.3%, p < 0.0001) than serum galactomannan (GM) (cut-off value of ≥1.0), and similar sensitivity (59.6% vs. 55.6%, p = 0.611) but lower specificity (77.0% vs. 91.2%, p = 0.001) than bronchoalveolar lavage fluid (BALF) GM (cut-off value of ≥1.0), respectively. Combination diagnosis of either positive for Asp IgG or BALF GM had higher sensitivity (81.0% vs. 55.6%, p = 0.002), but lower specificity (75.2% vs. 91.2%, p = 0.001) than BALF GM alone. The receiver operating characteristic curve showed that Asp IgG had an optimal diagnostic value when the cut-off value was 56.6 AU/ml, and the sensitivity and specificity were 77.8% and 63.9%, respectively. DISCUSSIONS: The diagnostic value of Asp IgG for IPA is superior to serum GM, and a little inferior to BALF GM in nonneutropenic patients with IPA. Considering the convenience of taking blood samples, it is a good screening and diagnostic method for nonneutropenic patients with IPA, especially for those who cannot bear invasive procedures.
引用
- Lu Y, Liu L, Li H, et al. The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis. Clin Microbiol Infect. 2023. PMID: 36773771. doi:10.1016/j.cmi.2023.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。